20152018

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 3 Conference contribution
  • 2 Article
  • 1 Meeting abstract
Filter
Conference contribution
2017

The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer

Van Schaeybroeck, S., Forsythe, N., Refaat, A., Javadi, A., Khawaja, H., Weir, J-A., Emam, H., Moore, W., Burkamp, F., Popovici, V., Jithesh, P., Isella, C., LaBonte Wilson, M., Mills, I. & Johnston, P., 2017, The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer. National Cancer Research Insitute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2016

ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

Weir, J-A., Gilliland, P., Fuchs, M-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2015

The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer

Weir, J-A., Redmond, K., Bradley, C. & Van Schaeybroeck, S., Nov 2015, The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer. National Cancer Research Institute, Vol. A87.

Research output: Chapter in Book/Report/Conference proceedingConference contribution